Next Article in Journal
Statistical Mechanical Treatments of Protein Amyloid Formation
Next Article in Special Issue
Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
Previous Article in Journal
Emerging Roles of Small Epstein-Barr Virus Derived Non-Coding RNAs in Epithelial Malignancy
Previous Article in Special Issue
Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease
Due to scheduled maintaince work on one of the switches in our server center, our websites and may experience short service dirsuptions of up to 5 minutes on 30 January 2015 00:00 PM EST time.
Int. J. Mol. Sci. 2013, 14(9), 17410-17419; doi:10.3390/ijms140917410

Delta Opioid Receptor and Its Peptide: A Receptor-Ligand Neuroprotection

 and *
Received: 30 July 2013 / Revised: 15 August 2013 / Accepted: 19 August 2013 / Published: 23 August 2013
(This article belongs to the Special Issue Pathology and Treatment of Central Nervous System Diseases)
View Full-Text   |   Download PDF [411 KB, uploaded 19 June 2014]   |   Browse Figure
Abstract: In pursuit of neurological therapies, the opioid system, specifically delta opioid receptors and delta opioid peptides, demonstrates promising therapeutic potential for stroke, Parkinson’s disease, and other degenerative neurological conditions. Recent studies offer strong evidence in support of the therapeutic use of delta opioid receptors, and provide insights into the underlying mechanisms of action. Delta opioid receptors have been shown to confer protective effects by mediating ionic homeostasis and activating endogenous neuroprotective pathways. Additionally, delta opioid agonists such as (D-Ala 2, D-Leu 5) enkephalin (DADLE) have been shown to decrease apoptosis and promote neuronal survival. In its entirety, the delta opioid system represents a promising target for neural therapies.
Keywords: stroke; delta opioid receptors; neuroprotection; DADLE; neuronal death stroke; delta opioid receptors; neuroprotection; DADLE; neuronal death
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Staples, M.; Acosta, S.; Tajiri, N.; Pabon, M.; Kaneko, Y.; Borlongan, C.V. Delta Opioid Receptor and Its Peptide: A Receptor-Ligand Neuroprotection. Int. J. Mol. Sci. 2013, 14, 17410-17419.

AMA Style

Staples M, Acosta S, Tajiri N, Pabon M, Kaneko Y, Borlongan CV. Delta Opioid Receptor and Its Peptide: A Receptor-Ligand Neuroprotection. International Journal of Molecular Sciences. 2013; 14(9):17410-17419.

Chicago/Turabian Style

Staples, Meaghan; Acosta, Sandra; Tajiri, Naoki; Pabon, Mibel; Kaneko, Yuji; Borlongan, Cesar V. 2013. "Delta Opioid Receptor and Its Peptide: A Receptor-Ligand Neuroprotection." Int. J. Mol. Sci. 14, no. 9: 17410-17419.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert